Ping Xu
4 papers in the catalog · China, Beijing, Baoding, Wuhan
Ping Xu: 4 papers in the catalog · China, Beijing, Baoding, Wuhan · Beijing Institute of Lifeomics, Beijing Institute of Lifeomics · Works on AI proteomics perspective, DiNovo, pNovoM
Affiliations
- Beijing Institute of Lifeomics · State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Proteome Research Center
- Beijing Institute of Lifeomics · State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences Beijing
- China Medical University · Program of Environmental Toxicology, School of Public Health
- Hebei University · College of Life Sciences
- National Center for Protein Sciences (Beijing) · State Key Laboratory of Medical Proteomics
- Wuhan University · Key Laboratory of Combinatorial Biosynthesis and Drug Discovery of Ministry of Education, School of Pharmaceutical Sciences
Elsewhere
Papers
- AI proteomics: from protein identification to virtual cells (2026, Nature Methods)
- DiNovo enables high-coverage and high-confidence de novo peptide sequencing via mirror proteases and deep learning (2026, Nature Communications)
- DiNovo: high-coverage, high-confidence de novo peptide sequencing using mirror proteases and deep learning (2025, bioRxiv)
- Precision De Novo Peptide Sequencing Using Mirror Proteases of Ac-LysargiNase and Trypsin for Large-scale Proteomics (2019, Molecular & Cellular Proteomics)
Methods and tools
Patents (1)
- WO2025156912A1 Direct-read precision de novo sequencing method for proteins and proteome and based on product ion type identification and full product-ion coverage ↗ (Academy of Military Medical Sciences, priority 2024-01-22, pending)
Patent families naming this author as an inventor. The link is made only where the same person is evident: they wrote a paper describing the patented method, or worked at the assignee.